Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia

被引:7
|
作者
Pawlowski, Matthias [1 ]
Lueg, Gero [1 ]
Gross, Catharina C. [1 ]
Johnen, Andreas [1 ]
Kraemer, Julia [1 ]
Weckesser, Matthias [2 ]
Wiendl, Heinz [1 ]
Meuth, Sven G. [1 ]
Duning, Thomas [1 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Munster, Germany
[2] Univ Hosp Munster, Dept Nucl Med, Munster, Germany
关键词
Frontotemporal dementia; Frontotemporal lobar degeneration; Primary progressive aphasia; Monocytes; Immune cell profiling; Cerebrospinal fluid; AMYOTROPHIC-LATERAL-SCLEROSIS; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; HEXANUCLEOTIDE REPEAT; DIAGNOSTIC-CRITERIA; BEHAVIORAL VARIANT; SEMANTIC DEMENTIA; PROGRANULIN; PATHOLOGY;
D O I
10.1016/j.neurobiolaging.2017.09.032
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood of patients with FTD. Thirty-two patients with behavioral variant frontotemporal dementia and 25 patients with primary progressive aphasia were included and compared to 14 healthy elderly controls. All patients underwent neuropsychological examination, magnetic resonance imaging, voxel-based diffusion tensor imaging, and peripheral blood and CSF immune cell profiling by multiparameter flow cytometry. The percentage of CSF monocytes was significantly increased specifically in patients with primary progressive aphasia. The proportion of monocytes in the CSF of the total FTD patient group directly correlated with semantic language impairment and microstructural temporal lesions. Increased intrathecal numbers of monocytes suggest a specific response of the innate immune system in a subset of patients with FTD. The findings are of clinical relevance since monocyte levels in the CSF were correlated with typical neuropsychological deficits and microstructural patterns of temporal degeneration. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [21] Cerebrospinal fluid glucose is not altered in patients with dementia
    Jensen, Camilla Steen
    Gleerup, Helena Sophia
    Musaeus, Christian Sandoe
    Hasselbalch, Steen Gregers
    Hogh, Peter
    Waldemar, Gunhild
    Simonsen, Anja Hviid
    CLINICAL BIOCHEMISTRY, 2023, 112 : 1 - 5
  • [22] Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
    Ione O. C. Woollacott
    Jennifer M. Nicholas
    Amanda Heslegrave
    Carolin Heller
    Martha S. Foiani
    Katrina M. Dick
    Lucy L. Russell
    Ross W. Paterson
    Ashvini Keshavan
    Nick C. Fox
    Jason D. Warren
    Jonathan M. Schott
    Henrik Zetterberg
    Jonathan D. Rohrer
    Alzheimer's Research & Therapy, 10
  • [23] Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia
    C. Liguori
    A. Romigi
    N. B. Mercuri
    M. Nuccetelli
    F. Izzi
    M. Albanese
    G. Sancesario
    A. Martorana
    G. M. Sancesario
    S. Bernardini
    M. G. Marciani
    F. Placidi
    Journal of Neurology, 2014, 261 : 1832 - 1836
  • [24] Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
    Roveta, Fausto
    Marcinno, Andrea
    Cremascoli, Riccardo
    Priano, Lorenzo
    Cattaldo, Stefania
    Rubino, Elisa
    Gallo, Erica
    Boschi, Silvia
    Mauro, Alessandro
    Rainero, Innocenzo
    NEUROLOGICAL SCIENCES, 2022, 43 (01) : 313 - 317
  • [25] Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
    Ljubenkov, Peter A.
    Staffaroni, Adam M.
    Rojas, Julio C.
    Allen, Isabel E.
    Wang, Ping
    Heuer, Hilary
    Karydas, Anna
    Kornak, John
    Cobigo, Yann
    Seeley, William W.
    Grinberg, Lea T.
    Spina, Salvatore
    Fagan, Anne M.
    Jerome, Gina
    Knopman, David
    Boeve, Brad F.
    Dickerson, Bradford C.
    Kramer, Joel
    Miller, Bruce
    Boxer, Adam L.
    Rosen, Howard J.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (10): : 1250 - 1263
  • [26] Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
    Fausto Roveta
    Andrea Marcinnò
    Riccardo Cremascoli
    Lorenzo Priano
    Stefania Cattaldo
    Elisa Rubino
    Erica Gallo
    Silvia Boschi
    Alessandro Mauro
    Innocenzo Rainero
    Neurological Sciences, 2022, 43 : 313 - 317
  • [27] Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia
    Tan, Yi Jayne
    Wong, Benjamin Y. X.
    Vaidyanathan, Ramanathan
    Sreejith, Sivaramapanicker
    Chia, Sook Yoong
    Kandiah, Nagaendran
    Ng, Adeline S. L.
    Zeng, Li
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 805 - 813
  • [28] Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia
    Minthon, L
    Edvinsson, L
    Gustafson, L
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (04) : 197 - 203
  • [29] Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer's Disease and Frontotemporal Dementia
    Alvarez-Sanchez, Lourdes
    Pena-Bautista, Carmen
    Ferre-Gonzalez, Laura
    Balaguer, Angel
    Baquero, Miguel
    Casanova-Estruch, Bonaventura
    Chafer-Pericas, Consuelo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [30] Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
    Irwin, David J.
    Trojanowski, John Q.
    Grossman, Murray
    FRONTIERS IN AGING NEUROSCIENCE, 2013, 5